Michael Kishbauch
Director/Board Member presso ASTRIA THERAPEUTICS, INC.
Patrimonio netto: - $ in data 31/03/2024
Profilo
Michael D.
Kishbauch was the founder of OraPharma, Inc. founded in 1996, where he held the title of President & Chief Executive Officer in 2004.
He is currently an Independent Director at Astria Therapeutics, Inc. since 2016.
Mr. Kishbauch received his undergraduate degree from Wesleyan University and his MBA degree from The Wharton School of the University of Pennsylvania.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
02/06/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Posizioni attive di Michael Kishbauch
Società | Posizione | Inizio |
---|---|---|
ASTRIA THERAPEUTICS, INC. | Director/Board Member | 05/04/2016 |
Precedenti posizioni note di Michael Kishbauch
Società | Posizione | Fine |
---|---|---|
ACHILLION PHARMACEUTICALS, INC. | Chief Executive Officer | 01/09/2013 |
PROGENICS PHARMACEUTICALS, INC. | Director/Board Member | 17/10/2019 |
TETRALOGIC PHARMACEUTICALS CORPORATION | Director/Board Member | 01/12/2016 |
ARIAD PHARMACEUTICALS, INC. | Director/Board Member | 01/12/2008 |
OraPharma, Inc.
OraPharma, Inc. Pharmaceuticals: MajorHealth Technology OraPharma, Inc. develops and produces drugs for oral diseases. It offers a suite of products to address a range of patient concerns from the foundation of gums, bone, and teeth to the aesthetics of a whiter smile. The company's products include ARESTIN Microspheres, a locally administered antibiotic indicated as an adjunct to scaling and root planning procedures for the reduction of pocket depth in patients with adult periodontitis; and ONSET Approach, a unique delivery system of locally buffered anesthesia that provides faster onset of anesthesia and a comfortable injection. The company was founded in 1996 and is headquartered in Horsham, PA. | Chief Executive Officer | 01/07/2004 |
Formazione di Michael Kishbauch
Wesleyan University | Undergraduate Degree |
The Wharton School of the University of Pennsylvania | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
TETRALOGIC PHARMACEUTICALS CORPORATION | Health Technology |
ASTRIA THERAPEUTICS, INC. | Health Technology |
Aziende private | 6 |
---|---|
Ciba-Geigy Corp. | Health Technology |
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Health Technology |
ARIAD Pharmaceuticals, Inc.
ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA. | Health Technology |
Progenics Pharmaceuticals, Inc.
Progenics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Progenics Pharmaceuticals, Inc. engages in the development of medicines and other products for targeting and treating cancer. Its pipeline includes therapeutic agents, imaging agents for prostate cancer, and imaging analysis technology. The company was founded by Paul J. Maddon on December 1, 1986 and is headquartered in New York, NY. | Health Technology |
OraPharma, Inc.
OraPharma, Inc. Pharmaceuticals: MajorHealth Technology OraPharma, Inc. develops and produces drugs for oral diseases. It offers a suite of products to address a range of patient concerns from the foundation of gums, bone, and teeth to the aesthetics of a whiter smile. The company's products include ARESTIN Microspheres, a locally administered antibiotic indicated as an adjunct to scaling and root planning procedures for the reduction of pocket depth in patients with adult periodontitis; and ONSET Approach, a unique delivery system of locally buffered anesthesia that provides faster onset of anesthesia and a comfortable injection. The company was founded in 1996 and is headquartered in Horsham, PA. | Health Technology |
Achillion Pharmaceuticals, Inc.
Achillion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Achillion Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of oral small molecule complement system inhibitors. Its pipeline includes Danicopan and ACH-5228. The company was founded on August 17, 1998 and is headquartered in Blue Bell, PA. | Health Technology |
- Borsa valori
- Insiders
- Michael Kishbauch